3 - 9 August 2019
These are links to news stories about multiple sclerosis from the last week that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.
Draft NICE guideline on medicinal cannabis published
NICE published its draft guideline on using cannabis-based medicinal products to treat nausea and vomiting that is difficult to control, chronic pain, spasticity and severe treatment-resistant epilepsy. The guideline does not recommend cannabis-based medicines for epilepsy, chronic pain or spasticity. Sativex is mentioned specifically as being too expensive to treat spasticity in MS.
Lack of residential care for younger people with disability
The lack of suitable housing for younger people with disability has been highlighted Nina Thair was diagnosed with MS at 29, continued to work, was promoted to assistant head teacher and traveled widely. Now aged 46, she is dependent on a wheelchair and unable to live in her own flat. She is currently living in an old people’s home because the local council says there is nowhere else suitable for her.
MS Trust link: Social care
MS in the Media
27 Nov 2020 - 00:00
- Depression affects multitasking in MS
- Benefits process in Scotland
- Cancer risks and multiple sclerosis
- Gut immune cells and relapses
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.